Insider Transactions in Q4 2023 at Sarepta Therapeutics, Inc. (SRPT)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2023
|
Bilal Arif Chief Tech Ops Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,682
-13.86%
|
$294,560
$80.34 P/Share
|
|
Nov 17
2023
|
Louise Rodino Klapac Head of R&D, CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,508
-6.42%
|
$369,656
$82.98 P/Share
|
|
Nov 03
2023
|
M Kathleen Behrens |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+7.9%
|
$435,000
$29.03 P/Share
|
|
Nov 03
2023
|
Douglas S Ingram President & CEO |
BUY
Open market or private purchase
|
Direct |
25,225
+1.61%
|
$1,992,775
$79.97 P/Share
|
|
Nov 03
2023
|
Richard Barry |
BUY
Open market or private purchase
|
Indirect |
50,000
+36.11%
|
$3,900,000
$78.81 P/Share
|